Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|July 4, 2014
Radiopharmacy: regulations and legislations in relation to human applicationsClemens Decristoforo, Sally W Schwarz
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2015
The role of exploratory investigational new drugs for translating radiopharmaceuticals into first-in-human studiesSally W Schwarz, Reiko Oyama
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2014
Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)TcCathy S Cutler, Sally W Schwarz
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2005
Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PETRichard Laforest, Farrokh Dehdashti, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2014
Regulatory Requirements for PET Drug ProductionSally W Schwarz, David Dick, Henry F VanBrocklin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 21, 2022
Proceedings: PET Drugs-A Workshop on Inspections Management and Regulatory ConsiderationsSue Bunning, Christopher Ignace, Steve Mattmuller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Harmonization of United States, European Union and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals-Is This Possible?Sally W Schwarz, Clemens Decristoforo, Anne E Goodbody, et al.
Radiology. Imaging Cancer|January 28, 2022
The Development of <sup>18</sup>F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.
Pageof 2